drugset / Trial / NCT00183404
Long-Term Olanzapine Treatment in Children With Autism
Phase 2/3
Completed
32 enrolled
Drexel University
National Institute of Mental Health (NIMH) · collab
NaSingle-groupOpen-labelTreatment
Summary
This study will determine the short- and long-term safety and effectiveness of the drug olanzapine (Zyprexa®) for reducing symptoms of autism in children.
Timeline
- Start
- 2004-09
- Primary completion
- 2011-07
- Completion
- 2011-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Olanzapine | Small molecule | 2.5 mg | — |
| Subject | Olanzapine | Small molecule | 20 mg | — |